Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
Will Parsons, Interim Director at Texas Children’s Cancer and Hematology Center, shared a post on LinkedIn:
”We’re proud to recognize the national leadership roles of (pictured L-R) Drs. Titilope Fasipe, Jacquelyn “Jackie” Powers and Venee Tubman in advancing care for children with blood disorders.
• Dr. Titi Fasipe serves as Chair of the National Heart, Lung, and Blood Institute (NHLBI) Sickle Cell Disease Advisory Committee and leads two American Society of Hematology (ASH) initiatives focused on community engagement and quality care.
• Dr. Jackie Powers is Clinical Chair for ASH’s guidelines on pediatric iron deficiency, one of the few national efforts focused on children.
• Dr. Tubman leads ASH’s global guidelines on hydroxyurea dosing and monitoring, helping standardize care for children with chronic blood disorders around the world.
Please join us in celebrating their continued leadership and impact on the lives of children and families affected by blood disorders.
The NHLBI is part of the The National Institutes of Health and is focused on advancing research and education on the prevention and treatment of heart, lung, blood and sleep disorders.
ASH is the world’s largest professional organization dedicated to advancing the understanding, diagnosis, treatment and prevention of blood and bone marrow disorders through transformative research, innovative education, and high-quality, equitable care.
Texas Children’s Hospital and The University of Texas MD Anderson Cancer Center are joining forces to launch the Kinder Children’s Cancer Center in 2026.”
Learn more on this initiative here.
Stay updated on the global initiatives in the World of Hematology with Hemostasis Today.
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins
-
Jul 4, 2026, 15:41Emmanuel J. Favaloro: New Research Highlights Benchmarks for Low Molecular Weight Heparin Monitoring
-
Jul 4, 2026, 15:38Roshni Kulkarni: Maternal Mortality In Bleeding Disorders
-
Jul 4, 2026, 15:34Alejandro González Veliz: Does Elevated Lp(a) Always Mean the Same Cardiovascular Risk?
-
Jul 4, 2026, 15:20Bruno Pougault: Heparin Monitoring Remains One of the Most Challenging Areas in Laboratory Hemostasis